Physician profile
Alan S Jin
NPI 1508146788
$4,773.64
in general payments reported to CMS, 2019-2025
7 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.67 · 2021: $343 · 2022: $821 · 2023: $1,503 · 2024: $1,028 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,569.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,094.62 | 2021-2025 | Acuvue |
| Coopervision INC. | $1,544.27 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $535.09 | 2020-2025 | Precision 1, Precision7, Rocklatan |
| Sun Pharmaceutical Industries INC. | $235.99 | 2023-2024 | Cequa, Xelpros |
| Bausch & Lomb Americas INC. | $210.17 | 2023-2025 | Infuse, Biotrue |
| Thea Pharma INC. | $142.29 | 2023-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Jin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.